Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
JNJJohnson & Johnson Live data
$278.21▼ -2.57 (-0.9%)as of Nov 11, 2026, 6:21 PM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$193.07$283.25
1-Month Range
Month up 11.9%
$248.61$282.11
Daily Price Range
Day down -0.9%
$276.59$278.66
Volume
vs 8M avg
2M8M avg
Profile
Identity and capital structure
SectorHealthcare
IndustryDrug Manufacturers—General
Market Cap$669.7B
Short % of Float—
Employees—
Sales—
Shares Outstanding2,407,318,213
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.jnj.com
Johnson & Johnson — is a public issuer in the Vantage universe..
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for JNJ.
Price targets unavailable — no 12-month targets on file for JNJ.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on JNJ, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:21 PM UTC